Hypercoagulable treatment addresses hypercoagulability (thrombophilia), a condition where blood clots excessively due to genetic or acquired factors. It increases risks of deep vein thrombosis (DVT), pulmonary embolism, and strokes. Common types include Factor V Leiden, Prothrombin 20210 mutation, and antiphospholipid syndrome. Treatments prevent thrombotic events using anticoagulants like...